Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | 1.32% | 247.03 | 1.3% | $806.38m | |
| IMMU | Immunomedics, Inc. | 0.19% | 85.52 | 11.0% | $698.49m | |
| MRNA | Moderna, Inc. | 1.56% | 70.55 | 0.0% | $676.85m | |
| NVAX | Novavax, Inc. | -2.10% | 111.18 | 96.5% | $615.83m | |
| ILMN | Illumina, Inc. | 1.86% | 305.46 | 3.5% | $593.62m | |
| GILD | Gilead Sciences, Inc. | 0.96% | 62.85 | 1.0% | $579.64m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.37% | 571.92 | 2.7% | $441.73m | |
| BIIB | Biogen, Inc. | 3.20% | 282.04 | 1.6% | $345.71m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.17% | 267.73 | 1.9% | $340.28m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.99% | 113.30 | 2.0% | $282.40m | |
| EXAS | EXACT Sciences Corp. | 2.05% | 99.70 | 20.7% | $262.56m | |
| SRNE | Sorrento Therapeutics, Inc. | 5.35% | 10.15 | 1.5% | $253.74m | |
| SGEN | Seattle Genetics, Inc. | 3.01% | 190.51 | 6.0% | $218.52m | |
| VXRT | Vaxart, Inc. | -5.41% | 7.00 | 0.0% | $202.32m | |
| MNTA | Momenta Pharmaceuticals, Inc. | 0.12% | 52.46 | 3.0% | $193.81m |
Company Profile
Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.